M&A Deal Summary

Element Materials Technology Acquires JMI Laboratories

On November 4, 2021, Element Materials Technology acquired life science company JMI Laboratories

Acquisition Highlights
  • This is Element Materials Technology’s 6th transaction in the Life Science sector.
  • This is Element Materials Technology’s 17th transaction in the United States.
  • This is Element Materials Technology’s 1st transaction in Iowa.

M&A Deal Summary

Date 2021-11-04
Target JMI Laboratories
Sector Life Science
Buyer(s) Element Materials Technology
Deal Type Add-on Acquisition
Advisor(s) BroadOak Capital Partners (Financial)

Target

JMI Laboratories

North Liberty, Iowa, United States
JMI Laboratories provides antimicrobial resistance monitoring studies utilized for US-FDA regulatory and new drug application submissions, through their proprietary SENTRY Antimicrobial Surveillance Program. It offers microbiology and molecular testing services to assist in the development of new antimicrobials and clinical trial support. JMI Laboratories was founded in 2000 and is based in North Liberty, Iowa.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Element Materials Technology

London, United Kingdom

Category Company
Founded 2011
Sector Test/Measurement Equipment
DESCRIPTION

Element Materials Technology is a provider of testing, inspection, and certification services for a diverse range of products, materials, and technologies in advanced industrial supply chains where failure in use is not an option. The company's scientists, engineers, and technologists, working in our global network of over 200 laboratories, support customers from early R&D, through complex regulatory approvals, and into production ensuring their products are safe and sustainable, and achieve market access. Element Materials Technology was formed in 2011 and is based in London.


DEAL STATS #
Overall 28 of 38
Sector (Life Science) 6 of 6
Type (Add-on Acquisition) 23 of 31
State (Iowa) 1 of 1
Country (United States) 17 of 22
Year (2021) 6 of 7
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-10-11 Nanosyn

Santa Clara, California, United States

Nanosyn is a full-service pharmaceuticals contract development and manufacturing organization. It has a track record of providing the highest quality services and operates three facilities in the San Francisco Bay Area of approximately 100,000 sq.ft, two of which are FDA registered. Nanosyn was formed in 1998 and is based in Santa Clara, California.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-12-02 Norton Straw

Derby, United Kingdom

Norton Straw is a consultant with deep technical expertise in engineering, applied mathematics, and technical software. The company uses its expertise and technology resources to provide insight, understanding, and answers to complex engineering and technology challenges. Norton Straw's team of experts works closely with our clients around the world across a wide range of industries. It aims to be a trusted and valued technology partner to clients and a company where people feel valued and enjoy delivering high-quality, specialist engineering and technology services. Norton Straw was formed in 2011 and is based in Derby, United Kingdom.

Buy -